Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Capital Leases (2023 - 2025)

Historic Capital Leases for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $1998.0.

  • bioAffinity Technologies' Capital Leases fell 9963.2% to $1998.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1998.0, marking a year-over-year decrease of 9963.2%. This contributed to the annual value of $444448.0 for FY2024, which is 4680.24% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Capital Leases is $1998.0, which was down 9963.2% from $3942.0 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Capital Leases high stood at $929570.0 for Q3 2023, and its period low was $1998.0 during Q3 2025.
  • Over the past 3 years, bioAffinity Technologies' median Capital Leases value was $543007.0 (recorded in 2024), while the average stood at $497263.9.
  • Per our database at Business Quant, bioAffinity Technologies' Capital Leases plummeted by 4158.51% in 2024 and then plummeted by 9963.2% in 2025.
  • Over the past 3 years, bioAffinity Technologies' Capital Leases (Quarter) stood at $835467.0 in 2023, then tumbled by 46.8% to $444448.0 in 2024, then plummeted by 99.55% to $1998.0 in 2025.
  • Its Capital Leases stands at $1998.0 for Q3 2025, versus $3942.0 for Q2 2025 and $335899.0 for Q1 2025.